Evidence map›Paper›PMID 37601045›Full record

ArticleFrontiers in pharmacology2023

Recommendations for wider adoption of clinical pharmacy in Central and Eastern Europe in order to optimise pharmacotherapy and improve patient outcomes.

Kamila Urbańczyk, Sonja Guntschnig, Vasilis Antoniadis, Slaven Falamic, Tijana Kovacevic, Marta Kurczewska-Michalak, Branislava Miljković, Anna Olearova, Inese Sviestina, Attila Szucs and 14 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 3 pooled it
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 3 syntheses or guidelines pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. A Qualitative Study to Explore Global Trends in Clinical Pharmacy Practice.Journal of evaluation in clinical practice · 2025
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 18 institutions in 15 countries.

Kamila UrbańczykDepartment of Clinical Pharmacology, Wroclaw Medical University, Wroclaw, Poland.
Sonja GuntschnigTauernklinikum Zell am See, Zell am See, Austria.
Vasilis AntoniadisIndependent Expert, Thessaloniki, Greece.
Slaven FalamicDepartment of Pharmacokinetics and Clinical Pharmacy, Faculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and Herzegovina.
Tijana KovacevicPharmacy Department, University Clinical Centre of the Republic of Srpska, Banja Luka, Bosnia and Herzegovina.
Marta Kurczewska-MichalakDepartment of Family Medicine, Medical University of Lodz, Lodz, Poland.
Branislava MiljkovićDepartment of Pharmacokinetics and Clinical Pharmacy, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia.
Anna OlearovaDepartment of Clinical Pharmacology, University Hospital Bratislava-Hospital Ruzinov, Bratislava, Slovakia.
Inese SviestinaFaculty of Medicine, University of Latvia, Riga, Latvia.
Attila SzucsPharmacy Department, National Institute of Oncology, Budapest, Hungary.
Konstantin TachkovDepartment of Organization and Economy of Pharmacy, Faculty of Pharmacy, Medical University-Sofia, Sofia, Bulgaria.
Zita TiszaiDepartment of Hospital Pharmacy, Bajcsy-Zsilinszky Hospital, Budapest, Hungary.
Daisy VolmerInstitute of Pharmacy, Faculty of Medicine, University of Tartu, Tartu, Estonia.
Anna Wiela-HojeńskaDepartment of Clinical Pharmacology, Wroclaw Medical University, Wroclaw, Poland.
Daniela FialovaDepartment of Clinical and Social Pharmacy, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czechia.
Jiri VlcekDepartment of Clinical and Social Pharmacy, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czechia.
Matej StuhecDepartment of Pharmacology, Faculty of Medicine Maribor, University of Maribor, Maribor, Slovenia.
Anita HoggMedicines Optimisation Innovation Centre, Antrim Hospital, Antrim, United Kingdom.
Michael ScottMedicines Optimisation Innovation Centre, Antrim Hospital, Antrim, United Kingdom.
Derek StewartCollege of Pharmacy, QU Health, Qatar University, Doha, Qatar.
Alpana MairEffective Prescribing and Therapeutics, Health and Social Care Directorate, Scottish Government, Edinburgh, United Kingdom.
Silvia RaveraEuropean Directorate for the Quality of Medicines & Healthcare, Council of Europe, Strasbourg, France.
François-Xavier LeryEuropean Directorate for the Quality of Medicines & Healthcare, Council of Europe, Strasbourg, France.
Przemysław KardasDepartment of Family Medicine, Medical University of Lodz, Lodz, Poland.
Antrim Area Hospital · GBCharles University · CZConseil de L'EuropeMedical University of Lodz · PLUniversity of Banja Luka · BAWroclaw Medical University · PLBajcsy-Zsilinszky Kórház és Rendelőintézet · HUComenius University Bratislava · SKHellenic Agency for Local Development and Local Government · GRMedical University of Sofia · BGNational Institute of Oncology · HUQatar University · QAScottish Government · GBUniversity of Belgrade · RSUniversity of Latvia · LVUniversity of Maribor · SIUniversity of Tartu · EEUniversity of Ulster · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clinical pharmacy as an area of practice, education and research started developing around the 1960s when pharmacists across the globe gradually identified the need to focus more on ensuring the appropriate use of medicines to improve patient outcomes rather than being engaged in manufacturing and supply. Since that time numerous studies have shown the positive impact of clinical pharmacy services (CPS). The need for wider adoption of CPS worldwide becomes urgent, as the global population ages, and the prevalence of polypharmacy as well as shortage of healthcare professionals is rising. At the same time, there is great pressure to provide both high-quality and cost-effective health services. All these challenges urgently require the adoption of a new paradigm of healthcare system architecture. One of the most appropriate answers to these challenges is to increase the utilization of the potential of highly educated and skilled professionals widely available in these countries, i.e., pharmacists, who are well positioned to prevent and manage drug-related problems together with ensuring safe and effective use of medications with further care relating to medication adherence. Unfortunately, CPS are still underdeveloped and underutilized in some parts of Europe, namely, in most of the Central and Eastern European (CEE) countries. This paper reviews current situation of CPS development in CEE countries and the prospects for the future of CPS in that region.

Indexed as

clinical pharmacycost-effective treatmentdrug safetydrug utilizationhealth policymedication adherencemedication errorspolypharmacy

Identifiers

PMID37601045
PMCPMC10433912
OpenAlexW4385492756

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.